No Matches Found
No Matches Found
No Matches Found
Yatharth Hospital & Trauma Care Services Ltd
Yatharth Hospital & Trauma Care Services Ltd Shows Signs of Technical Momentum Shift Amid Mixed Indicators
Yatharth Hospital & Trauma Care Services Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend. This change is underscored by a blend of mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors in the hospital sector.
Yatharth Hospital & Trauma Care Services Ltd Faces Technical Momentum Shift Amid Bearish Signals
Yatharth Hospital & Trauma Care Services Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from sideways movement to a mildly bearish trend. Despite some bullish cues on shorter-term oscillators, the overall technical landscape suggests caution for investors as the stock price declined by 3.04% on 27 Jan 2026, reflecting growing selling pressure amid broader market challenges.
Yatharth Hospital & Trauma Care Services Ltd is Rated Hold
Yatharth Hospital & Trauma Care Services Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 January 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 23 January 2026, providing investors with the latest insights into its performance and outlook.
Yatharth Hospital & Trauma Care Services Ltd: Technical Momentum Shifts Amid Mixed Signals
Yatharth Hospital & Trauma Care Services Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways pattern. Despite a modest day gain of 1.27%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum tools, prompting a reassessment of its near-term outlook.
Yatharth Hospital & Trauma Care Services Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
Yatharth Hospital & Trauma Care Services Ltd has seen its investment rating downgraded from Hold to Sell as of 09 January 2026, reflecting a complex interplay of valuation concerns, technical indicators, financial trends, and quality assessments. Despite delivering positive quarterly results and outperforming the market over the past year, the stock faces headwinds from expensive valuations, subdued long-term growth, and weakening technical momentum.
Yatharth Hospital & Trauma Care Services Ltd Faces Technical Momentum Shift Amid Mixed Indicators
Yatharth Hospital & Trauma Care Services Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways pattern. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid recent price declines and sector headwinds.
Yatharth Hospital & Trauma Care Services Ltd is Rated Sell
Yatharth Hospital & Trauma Care Services Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 09 Jan 2026, reflecting a reassessment of the stock's outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 10 January 2026, providing investors with the latest perspective on the company’s position.
Yatharth Hospital & Trauma Care Services Ltd is Rated Hold
Yatharth Hospital & Trauma Care Services Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Yatharth Hospit. Sees Revision in Market Assessment Amid Mixed Financial Signals
Yatharth Hospit., a small-cap player in the hospital sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of steady operational performance and valuation considerations that investors should carefully analyse.
Yatharth Hospital & Trauma Care Services Sees High-Value Trading Amid Volatile Market
Yatharth Hospital & Trauma Care Services Ltd has emerged as one of the most actively traded stocks by value in the hospital sector, registering significant turnover and notable volatility on 28 November 2025. Despite a challenging session marked by a sharp decline in share price, the stock attracted substantial investor attention, reflecting heightened market interest and dynamic trading activity.
Yatharth Hospital & Trauma Care Services Hits Intraday Low Amid Price Pressure
Shares of Yatharth Hospital & Trauma Care Services experienced notable intraday weakness on 28 Nov 2025, touching a low of Rs 702.8 as the stock faced significant price pressure, underperforming its sector and broader market indices.
Yatharth Hospit. Sees Revision in Market Assessment Amid Mixed Financial Signals
Yatharth Hospit., a small-cap player in the hospital sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of solid recent returns and evolving fundamentals, prompting investors to reassess the stock’s position within its sector and the broader market.
Yatharth Hospital Q2 FY26: Strong Revenue Growth Masks Margin Pressure and Valuation Concerns
Yatharth Hospital & Trauma Care Services Ltd. reported net profit of ₹41.25 crores for Q2 FY26, reflecting a marginal decline of 1.90% quarter-on-quarter but a robust year-on-year growth of 33.25%. The healthcare provider, with a market capitalisation of ₹7,213 crores, delivered its strongest-ever quarterly revenue of ₹279.42 crores, marking 28.31% year-on-year expansion. However, the headline growth numbers obscure emerging concerns around margin compression, elevated valuation multiples, and declining return on equity that warrant careful investor scrutiny.
How has been the historical performance of Yatharth Hospit.?
Yatharth Hospital has shown significant growth from March 2022 to March 2025, with net sales increasing from 400.94 crore to 880.49 crore, and profit after tax rising from 44.16 crore to 130.55 crore, alongside a substantial improvement in total assets and cash flow. Overall, the hospital has demonstrated robust revenue and profitability growth during this period.
How has been the historical performance of Yatharth Hospit.?
Yatharth Hospital has shown significant growth over the past four years, with net sales increasing from INR 400.94 crore to INR 880.49 crore, and profit after tax rising from INR 44.16 crore to INR 130.55 crore, alongside improved financial stability and a reduction in total debt. Total assets surged from INR 420.57 crore to INR 1,713.06 crore, reflecting robust revenue and profitability growth.
Why is Yatharth Hospit. falling/rising?
As of 07-Nov, Yatharth Hospital & Trauma Care Services Ltd's stock price is Rs 784.95, down 1.26% today and has declined 4.43% over the last two days. Despite this short-term drop, the stock has a positive monthly return of 3.08% and a strong yearly return of 17.69%, supported by solid fundamentals and low debt.
Is Yatharth Hospit. technically bullish or bearish?
As of November 3, 2025, Yatharth Hospital's technical trend is mildly bullish, supported by a bullish MACD and moving averages, though caution is advised due to a mildly bearish KST and lack of momentum in the RSI.
Yatharth Hospital Shows Resilience Amid Mixed Technical Signals in Market Dynamics
Yatharth Hospital & Trauma Care Services has shown strong performance in the hospital sector, with a notable annual return of 20.35%, significantly surpassing the Sensex. The stock's recent price increase and positive technical indicators reflect its resilience and potential for continued growth in a competitive market.
Is Yatharth Hospit. overvalued or undervalued?
As of October 8, 2025, Yatharth Hospital is considered very expensive and overvalued, with a PE ratio of 56.35, an EV to EBITDA of 32.50, and a Price to Book Value of 4.99, despite having a lower PE ratio than peers like Max Healthcare and Fortis Healthcare, while significantly outperforming the Sensex with a year-to-date return of 46.93%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
